Overview

Gender

male

Graham Cooper joined us as Chief Financial Officer in February 2013.

Prior to joining us, during 2012, Graham Cooper was the Executive Vice President, Finance and Chief Financial Officer of Geron Corporation, a biopharmaceutical company focused on cancer therapies.

From 2006 until 2011, Graham Cooper served as Senior Vice President, Chief Financial Officer and Treasurer of Orexigen Therapeutics, Inc., a biotechnology company focused on obesity.

From 1999 to 2006, Graham Cooper held positions of increasing responsibility including Director, Health Care Investment Banking, at Deutsche Bank Securities, where he was responsible for executing and managing a wide variety of financing and merger and acquisition transactions in the life sciences field.

From August 1992 to January 1995, he worked as an accountant at Deloitte & Touche, and was previously a C.P.A.

Graham Cooper holds a B.A. in Economics from the University of California at Berkeley and an M.B.A. from the Stanford Graduate School of Business.